Cas no 1353679-63-6 (4-Bromo-1-methyl-1H-1,3-benzodiazole)
4-Bromo-1-methyl-1H-1,3-benzodiazole Chemical and Physical Properties
Names and Identifiers
-
- 4-Bromo-1-methyl-1H-benzimidazole
- 4-Bromo-1-methyl-1H-benzo[d]imidazole
- 4-bromo-1-methyl-1H-1,3-benzodiazole
- 4-Bromo-1-methyl-1H-benzoimidazole
- 4-bromo-1-methylbenzimidazole
- 2-butylnoic acid
- 1H-Benzimidazole, 4-bromo-1-methyl-
- NE52930
- CM13871
- AS06203
- CM13870
- AK154861
- 4-BROMO-1-METHYL-1,3-BENZODIAZOLE
- SY113269
- AKOS022691241
- 1353679-63-6
- DK-0044
- PB48305
- MFCD18378523
- DB-099817
- CS-0037180
- Z1269128357
- 4-bromo-1-methyl-benzimidazole
- EN300-125592
- SCHEMBL9981117
- 826-635-0
- 4-Bromo-1-methyl-1H-1,3-benzodiazole
-
- MDL: MFCD18378523
- Inchi: 1S/C8H7BrN2/c1-11-5-10-8-6(9)3-2-4-7(8)11/h2-5H,1H3
- InChI Key: RQJWIWNNDYLKNI-UHFFFAOYSA-N
- SMILES: BrC1=CC=CC2=C1N=CN2C
Computed Properties
- Exact Mass: 209.97926g/mol
- Monoisotopic Mass: 209.97926g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 1
- Heavy Atom Count: 11
- Rotatable Bond Count: 0
- Complexity: 151
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 17.8
- XLogP3: 2.1
Experimental Properties
- Density: 1.60±0.1 g/cm3 (20 oC 760 Torr),
- Solubility: Slightly soluble (2.1 g/l) (25 o C),
4-Bromo-1-methyl-1H-1,3-benzodiazole Security Information
- Signal Word:Warning
- Hazard Statement: H302-H315-H320-H335
- Warning Statement: P261-P280-P301+P312-P302+P352-P305+P351+P338
- Storage Condition:Sealed in dry,Room Temperature(BD283064)
4-Bromo-1-methyl-1H-1,3-benzodiazole Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-VG689-250mg |
4-Bromo-1-methyl-1H-1,3-benzodiazole |
1353679-63-6 | 95+% | 250mg |
1085CNY | 2021-05-07 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-VG689-50mg |
4-Bromo-1-methyl-1H-1,3-benzodiazole |
1353679-63-6 | 95+% | 50mg |
87.0CNY | 2021-07-10 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-VG689-1g |
4-Bromo-1-methyl-1H-1,3-benzodiazole |
1353679-63-6 | 95+% | 1g |
522.0CNY | 2021-07-10 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-VG689-5g |
4-Bromo-1-methyl-1H-1,3-benzodiazole |
1353679-63-6 | 95+% | 5g |
1764.0CNY | 2021-07-10 | |
| Chemenu | CM133437-1g |
4-bromo-1-methyl-1H-benzo[d]imidazole |
1353679-63-6 | 95% | 1g |
$309 | 2021-06-09 | |
| Chemenu | CM133437-5g |
4-bromo-1-methyl-1H-benzo[d]imidazole |
1353679-63-6 | 95% | 5g |
$870 | 2021-06-09 | |
| Alichem | A019065061-1g |
4-bromo-1-methyl-1H-benzimidazole |
1353679-63-6 | 95% | 1g |
429.00 USD | 2021-06-17 | |
| Alichem | A019065061-5g |
4-bromo-1-methyl-1H-benzimidazole |
1353679-63-6 | 95% | 5g |
1,209.00 USD | 2021-06-17 | |
| ChemScence | CS-0037180-250mg |
4-Bromo-1-methyl-1H-benzo[d]imidazole |
1353679-63-6 | 99.41% | 250mg |
$27.0 | 2022-04-27 | |
| ChemScence | CS-0037180-1g |
4-Bromo-1-methyl-1H-benzo[d]imidazole |
1353679-63-6 | 99.41% | 1g |
$67.0 | 2022-04-27 |
4-Bromo-1-methyl-1H-1,3-benzodiazole Related Literature
-
Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
-
Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
-
Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
-
Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
-
Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
Additional information on 4-Bromo-1-methyl-1H-1,3-benzodiazole
Comprehensive Overview of 4-Bromo-1-methyl-1H-1,3-benzodiazole (CAS No. 1353679-63-6): Properties, Applications, and Industry Insights
4-Bromo-1-methyl-1H-1,3-benzodiazole (CAS 1353679-63-6) is a heterocyclic organic compound that has garnered significant attention in pharmaceutical and agrochemical research due to its versatile structural framework. This benzodiazole derivative is characterized by a bromine substituent at the 4-position and a methyl group at the 1-position, which enhances its reactivity and utility in synthetic chemistry. Researchers and industries are increasingly exploring its potential as a building block for drug discovery, particularly in the development of kinase inhibitors and antimicrobial agents.
The compound's molecular formula, C8H7BrN2, and its unique chemical properties make it a valuable intermediate in organic synthesis. Recent studies highlight its role in cross-coupling reactions, such as Suzuki-Miyaura and Buchwald-Hartwig couplings, which are pivotal for constructing complex molecules. With the growing demand for small-molecule therapeutics, 4-Bromo-1-methyl-1H-1,3-benzodiazole has emerged as a key candidate for optimizing drug-like properties, including bioavailability and metabolic stability.
In the context of green chemistry, this compound aligns with the industry's shift toward sustainable synthesis methods. Its compatibility with catalytic processes reduces the need for hazardous reagents, addressing environmental concerns. Additionally, its applications extend to material science, where it contributes to the design of organic semiconductors and luminescent materials. As the demand for high-performance electronic materials rises, 4-Bromo-1-methyl-1H-1,3-benzodiazole offers a promising avenue for innovation.
From a commercial perspective, the global market for benzodiazole derivatives is expanding, driven by their use in pharmaceutical intermediates and agrochemical formulations. Suppliers and manufacturers are investing in scalable production methods to meet the needs of research institutions and industrial players. Frequently searched terms like "buy 4-Bromo-1-methyl-1H-1,3-benzodiazole" and "CAS 1353679-63-6 suppliers" reflect its rising demand. Quality control and regulatory compliance remain critical, ensuring the compound's suitability for GMP-grade applications.
Looking ahead, the integration of AI-driven drug discovery and computational chemistry is expected to further elevate the significance of 4-Bromo-1-methyl-1H-1,3-benzodiazole. Its structural motifs are being analyzed via machine learning algorithms to predict novel biological activities, accelerating the development of next-generation therapeutics. As researchers continue to explore its potential, this compound is poised to play a pivotal role in advancing precision medicine and sustainable chemical innovation.
1353679-63-6 (4-Bromo-1-methyl-1H-1,3-benzodiazole) Related Products
- 1379361-12-2(4-bromo-1,2-dimethyl-1H-1,3-benzodiazole)
- 1240610-45-0(4-Bromo-2-chloro-1-methyl-1H-benzodimidazole)
- 23073-51-0(5-Bromo-1-ethylbenzoimidazole)
- 317840-04-3(7-Bromo-1-methyl-1H-imidazo[4,5-c]pyridine)
- 53484-15-4(5-bromo-1-methyl-1H-1,3-benzodiazole)
- 813449-00-2(6-bromo-1-ethyl-1H-1,3-benzodiazole)
- 1147015-11-9(7-bromo-1-(propan-2-yl)-1H-1,3-benzodiazole)
- 53484-16-5(6-bromo-1-methyl-1H-1,3-benzodiazole)
- 166047-14-9(6-bromo-1-methyl-1H-imidazo4,5-bpyridine)
- 1233542-00-1(7-Bromo-1-methylbenzodiazole)